Biotechnology
12 articles
Interoception: A New Frontier in Aging Research
In a groundbreaking move, Life Biosciences administered its experimental glaucoma treatment to a human volunteer in 2026.
Life Biosciences Closes $80M to Advance Rejuvenation Therapies
A patient with glaucoma has received the first dose of ER-100, an experimental treatment from Life Biosciences.
Gene editing advancements promise new treatments for complex diseases
CRISPR-Cas12a2 has selectively killed cells with a cancer-causing mutation, leaving healthy cells unaffected, according to Utah State University .
AI Accelerates Whole-Body Rejuvenation Drug Discoveries
Biotech startup NewLimit recently secured $435 million from investors, including Founders Fund, for its age reprogramming efforts.
New antibody Fab5 shows broad high-affinity targeting of gammaherpesvirus gB
A single monoclonal antibody, Fab5, has demonstrated effective protection against three distinct gammaherpesviruses.
What is Synthetic Biology Design for New Biological Systems Applications?
A newly demonstrated genetic data converter can logarithmically encode molecular inputs with a staggering 100 dB dynamic range, directly rivaling and even surpassing the performance of high-performanc
AI Leaders Urge Lawmakers to Regulate Synthetic DNA
In an unprecedented move, the CEOs of OpenAI, Anthropic, and Google DeepMind publicly urged US lawmakers in 2026 to enact strict regulations on synthetic DNA, fearing AI's potential to accelerate biow
Top 5 Lucrative Biotechnology Careers for 2026
Bioinformaticians with expertise in AI/ML now command average salaries 20% higher than their peers, often exceeding $150,000 annually, according to a BioTalent Canada 2023 Report .
Colossal Foundation secures $50M for genetic rescue, de-extinction
Just over a year after its launch, the Colossal Foundation has doubled its secured funding to $100 million, fueling ambitious projects to bring back extinct species and genetically rescue others, acco
Verve gene editor lowers cholesterol in new study
A single infusion of Verve's experimental gene editor, VERVE-102, slashed patients' LDL cholesterol by 62% in a recent study, offering a potential one-time solution for a lifelong condition.
AI designs miniproteins to precisely control GPCR signaling
For the first time, artificial intelligence has designed custom miniproteins that precisely modulate G protein-coupled receptor (GPCR) signaling in cells.
Scientists use aptamers to identify aging cells in longevity research
A low-dose, 1mg/day regimen of rapamycin improved diastolic heart function in older men in just eight weeks, according to gethealthspan .